Verrica Pharmaceuticals Inc. (VRCA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 5.02M | 5.09M | 14.34M | 12.7M | 3.44M | 344K | -1.78M | 5.18M | 3.83M | 1.99M | 2.92M | 182K | 37K | 68K | 8.32M | 214K | 431K | 0 | 0 | 0 |
| Revenue Growth % | 46.06% | 1380.23% | 905.39% | 145.35% | -10.12% | -82.7% | -161.06% | 2744.51% | 10240.54% | 2823.53% | -64.94% | -14.95% | -91.42% | - | - | - | -96.41% | - | - | - |
| Cost of Goods Sold | 889K | 1.4M | 1.11M | 494K | 423K | 625K | 435K | 542K | 1.14M | 20.57M | 145K | 136K | 68K | 3.09M | 166K | 219K | 278K | 200K | 111K | 94K |
| COGS % of Revenue | 17.7% | 27.51% | 7.73% | 3.89% | 12.3% | 181.69% | -24.42% | 10.47% | 29.74% | 1034.56% | 4.97% | 74.73% | 183.78% | 4544.12% | 2% | 102.34% | 64.5% | - | - | - |
| Gross Profit | 4.13M | 3.69M | 13.23M | 12.21M | 3.02M | -281K | -2.22M | 4.63M | 2.69M | -18.58M | 2.77M | 46K | -31K | -3.02M | 8.15M | -5K | 153K | -200K | -111K | -94K |
| Gross Margin % | 82.3% | 72.49% | 92.27% | 96.11% | 87.7% | -81.69% | 124.42% | 89.53% | 70.26% | -934.56% | 95.03% | 25.27% | -83.78% | -4444.12% | 98% | -2.34% | 35.5% | - | - | - |
| Gross Profit Growth % | 37.07% | 1413.52% | 697.25% | 163.39% | 12.2% | 98.49% | -179.94% | 9976.09% | 8770.97% | -514.79% | -66% | 1020% | -120.26% | -1411% | 7445.05% | 94.68% | -98.72% | - | - | - |
| Operating Expenses | 13.85M | 10.64M | 11.61M | 10.7M | 11.15M | 11.13M | 18.49M | 19.84M | 21.29M | 4.56M | 26.69M | 11.66M | 7.06M | 3.19M | 6.71M | 9.12M | 7.56M | 8.27M | 11.66M | 10.64M |
| OpEx % of Revenue | 275.71% | 208.9% | 80.93% | 84.22% | 324.11% | 3235.17% | -1038.07% | 383.25% | 556.38% | 229.23% | 914.95% | 6407.69% | 19075.68% | 4689.71% | 80.6% | 4259.81% | 1754.76% | - | - | - |
| Selling, General & Admin | 9.99M | 8.12M | 9.4M | 8.85M | 8.85M | 9.88M | 16.08M | 16.52M | 16.34M | 17M | 20.05M | 5.94M | 4.32M | 3.19M | 3.92M | 5.17M | 5.12M | 4.91M | 7.89M | 7.19M |
| SG&A % of Revenue | 198.87% | 159.41% | 65.55% | 69.69% | 257.28% | 2871.51% | -903.03% | 319.14% | 427.05% | 854.88% | 687.49% | 3262.09% | 11672.97% | 4689.71% | 47.18% | 2417.29% | 1187.47% | - | - | - |
| Research & Development | 3.86M | 2.52M | 2.21M | 1.85M | 2.28M | 1.17M | 2.4M | 3.32M | 4.95M | 5.32M | 6.51M | 5.72M | 2.74M | 3.03M | 2.78M | 3.94M | 2.44M | 3.36M | 3.76M | 3.45M |
| R&D % of Revenue | 76.85% | 49.49% | 15.37% | 14.53% | 66.41% | 339.24% | -135.04% | 64.11% | 129.33% | 267.61% | 223.17% | 3145.6% | 7402.7% | 4452.94% | 33.42% | 1842.52% | 567.29% | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 14K | 84K | 0 | 0 | 0 | -1000K | 125K | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.71M | -6.95M | 1.63M | 1.51M | -8.13M | -11.41M | -20.7M | -15.21M | -18.6M | -23.14M | -23.92M | -11.62M | -7.09M | -6.21M | 1.45M | -9.12M | -7.41M | -8.47M | -11.77M | -10.73M |
| Operating Margin % | -193.41% | -136.41% | 11.34% | 11.89% | -236.41% | -3316.86% | 1162.49% | -293.72% | -486.12% | -1163.78% | -819.92% | -6382.42% | -19159.46% | -9133.82% | 17.41% | -4262.15% | -1719.26% | - | - | - |
| Operating Income Growth % | -19.5% | 39.12% | 107.86% | 109.93% | 56.29% | 50.68% | 13.43% | -30.91% | -162.36% | -272.5% | -1751.73% | -27.35% | 4.33% | 26.67% | 112.3% | 15% | -12450% | 29.61% | -22.11% | -24.33% |
| EBITDA | -9.52M | -6.76M | 1.81M | 1.71M | -7.92M | -11.16M | -20.36M | -14.87M | -18.26M | -22.98M | -23.71M | -11.41M | -6.89M | -6.08M | 1.77M | -9.02M | -7.31M | -8.27M | -11.66M | -10.64M |
| EBITDA Margin % | -189.55% | -132.68% | 12.63% | 13.45% | -230.36% | -3243.31% | 1143.29% | -287.27% | -477.23% | -1156.19% | -812.72% | -6268.68% | -18613.51% | -8941.18% | 21.26% | -4216.36% | -1696.52% | - | - | - |
| EBITDA Growth % | -20.18% | 39.45% | 108.89% | 111.49% | 56.61% | 51.46% | 14.11% | -30.35% | -165.12% | -278.04% | -1440.14% | -26.44% | 5.81% | 26.48% | 115.18% | 15.17% | -5857.48% | 30.12% | -21.02% | -23.41% |
| D&A (Non-Cash Add-back) | 194K | 190K | 184K | 199K | 208K | 253K | 342K | 334K | 340K | 151K | 210K | 207K | 202K | 131K | 321K | 98K | 98K | 200K | 111K | 94K |
| EBIT | -9.71M | -6.76M | 1.82M | 2.33M | -7.54M | -13.85M | -20.48M | -14.82M | -18.01M | -20.6M | -23.14M | -10.99M | -6.59M | -6.21M | 164K | -9.1M | -7.39M | -8.44M | -11.74M | -10.7M |
| Net Interest Income | 41K | -1.11M | -1.94M | -1.9M | -1.87M | -2.14M | -2.15M | -1.98M | -1.72M | -1.51M | -835K | 626K | 500K | 286K | 67K | -1.05M | -1.06M | -1.07M | -1.06M | -1.04M |
| Interest Income | 201K | 205K | 159K | 228K | 337K | 205K | 221K | 393K | 598K | 792K | 822K | 626K | 500K | 287K | 148K | 20K | 22K | 27K | 31K | 33K |
| Interest Expense | 160K | 1.31M | 2.09M | 2.13M | 2.2M | 2.35M | 2.38M | 2.37M | 2.32M | 2.31M | 1.66M | 0 | 0 | 0 | 81K | 1.07M | 1.08M | 1.1M | 1.09M | 1.08M |
| Other Income/Expense | 33K | -1.13M | -1.9M | -1.31M | -1.61M | -4.79M | -2.16M | -1.98M | -1.73M | -1.48M | -885K | 626K | 500K | 279K | -1.36M | -1.05M | -1.06M | -1.07M | -1.06M | -1.04M |
| Pretax Income | -9.68M | -8.07M | -274K | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.93M | 83K | -10.17M | -8.47M | -9.54M | -12.83M | -11.78M |
| Pretax Margin % | -192.75% | -158.56% | -1.91% | 1.61% | -283.28% | -4709.88% | 1283.55% | -331.97% | -531.39% | -1238.13% | -850.26% | -6038.46% | -17808.11% | -8723.53% | 1% | -4751.4% | -1965.2% | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -9.68M | -8.07M | -274K | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.93M | 83K | -10.17M | -8.47M | -9.54M | -12.83M | -11.78M |
| Net Margin % | -192.75% | -158.56% | -1.91% | 1.61% | -283.28% | -4709.88% | 1283.55% | -331.97% | -531.39% | -1238.13% | -850.26% | -6038.46% | -17808.11% | -8723.53% | 1% | -4751.4% | -1965.2% | - | - | - |
| Net Income Growth % | 0.62% | 50.17% | 98.8% | 101.19% | 52.08% | 34.18% | 7.83% | -56.38% | -208.56% | -314.94% | -29981.93% | -8.08% | 22.21% | 37.82% | 100.65% | 13.65% | -804.91% | 26.49% | -22.34% | -25.15% |
| Net Income (Continuing) | -9.68M | -8.07M | -274K | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.93M | 83K | -10.17M | -8.47M | -9.54M | -12.83M | -11.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.91 | -0.64 | -0.03 | 0.02 | -1.03 | -2.41 | -4.88 | -3.70 | -4.37 | -5.31 | -5.38 | -2.39 | -1.53 | -1.44 | 0.02 | -3.69 | -3.08 | -3.47 | -4.66 | -4.28 |
| EPS Growth % | 11.65% | 73.44% | 99.39% | 100.58% | 76.43% | 54.61% | 9.29% | -54.59% | -185.34% | -267.86% | -29024.73% | 35.22% | 50.24% | 58.36% | 100.4% | 13.66% | -741.88% | 33.05% | -11.11% | -13.56% |
| EPS (Basic) | -0.91 | -0.64 | -0.03 | 0.02 | -1.03 | -2.41 | -4.88 | -3.70 | -4.37 | -5.31 | -5.38 | -2.39 | -1.53 | -1.44 | 0.02 | -3.69 | -3.08 | -3.47 | -4.66 | -4.28 |
| Diluted Shares Outstanding | 10.65M | 10.65M | 9.49M | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.47M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M |
| Basic Shares Outstanding | 10.65M | 10.65M | 9.49M | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.03M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |